Elisabete Aparecida Mantovani Rodrigues de Resende

Elisabete Aparecida Mantovani Rodrigues de Resende

Auto-generated profile, based on publicly available information

Elisabete Aparecida Mantovani Rodrigues de Resende

Universidade Federal do Triângulo Mineiro

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Clinics
Verified
Journal Article
Open access
MBMaria de Fátima Borges
Maria de Fátima Borges
FTFlávia Carolina Cândida Teixeira
Flávia Carolina Cândida Teixeira
AFAline Karin Feltrin
Aline Karin Feltrin
KRKarina Alvarenga Ribeiro
Karina Alvarenga Ribeiro
GNGabriel Antonio Nogueira Nascentes
Gabriel Antonio Nogueira Nascentes
HPHeloísa Marcelina Cunha Palhares
Heloísa Marcelina Cunha Palhares
To establish cut-off values for growth hormone concentrations using clonidine as a secretagogue and an immunochemiluminescent assay as the method of measurement and to analyze the response time as well as the influence of gender, nutritional status and pubertal stage. A total of 225 tests were performed in 3 patient groups, categorized as group 1 (normal), group 2 (idiopathic short stature) and group 3 (growth hormone deficiency). Among the 199 disease-free individuals, 138 were prepubertal, and 61 were pubertal. Clonidine (0.1 mg/m2) was orally administered, and the growth hormone level was measured by immunochemiluminescent assay. The growth hormone peak and the difference between the growth hormone peak and the baseline level were then analyzed. Statistical analyses were performed using Student's t-test or the Mann-Whitney test and Kruskal-Wallis test followed by Dunn's post hoc test. Cut-off values were determined using a receiver operating characteristic curve. Group 1 and group 2 had no difference in growth hormone peak, gender, body mass index standard deviation score, or pubertal stage. Group 3 exhibited a significantly lower growth hormone peak than the other groups did. The receiver operating characteristic curve demonstrated that growth hormone concentrations ≥ 3.0 ng/mL defined responsiveness to clonidine. In total, 3.02% of individuals in group 1 and group 2 were considered false positive, i.e., these children lacked growth hormone deficiency and had a peak below 3.0 ng/mL. Clonidine-stimulated growth hormone concentrations ≥3 ng/mL, as measured by immunochemiluminescent assay, suggest responsiveness to the stimulus regardless of gender, body mass index standard deviation score or pubertal stage.

28 August 2019 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
TSTayssia Beatriz dos Santos
Tayssia Beatriz dos Santos
HPHelena Korres de Paula
Helena Korres de Paula
MBMarly Aparecida Spadotto Balarin
Marly Aparecida Spadotto Balarin
RSRoseane Lopes Silva-Grecco
Roseane Lopes Silva-Grecco
MLMarco Fábio Prata Lima
Marco Fábio Prata Lima
MCMariângela Torreglosa Ruiz Citra
Mariângela Torreglosa Ruiz Citra
Key words: Polycystic ovary syndrome; folic acid; polymorphism

1 November 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
MAMariana Mendes Porto Azevedo
Mariana Mendes Porto Azevedo
AMAlessandra Bernadete Trovó de Marqui
Alessandra Bernadete Trovó de Marqui
BBBruna Tavares Bacalá
Bruna Tavares Bacalá
MBMarly Aparecida Spadotto Balarin
Marly Aparecida Spadotto Balarin
ERElisabete Aparecida Mantovanni Rodrigues de Resende
Elisabete Aparecida Mantovanni Rodrigues de Resende
MCMariângela Torreglosa Ruiz Citra
Mariângela Torreglosa Ruiz Citra
SUMMARY BACKGROUND: This study aimed to investigate the deletion polymorphisms of the genes of the glutathione S-transferase family GSTT1 and GSTM1 in patients with Polycystic Ovarian Syndrome (PCOS), comparing them with a control population. METHODS: Blood was collected from 219 women (110 with PCOS and 109 controls) and genomic DNA was extracted. For the analysis of polymorphisms, the technique used was multiplex PCR. In the statistical analysis, the chi-square test and multiple logistic regression were used. RESULTS: There is no association between the GSTM1 null and GSTT1 null genotypes with PCOS when analyzed separately (P = 0.616 and P = 0.188). The analysis of the combined genotypes showed differences between the groups (P < 0.05), evidencing that the genotypic combination GSTT1 positive and GSTM1 negative is more frequent among patients. In the multivariate analysis, smoking was more frequent in the control group (OR = 0.22; 95% CI - 0.87-0.57; P = 0.002) while the presence of a family history of PCOS (OR = 2, 96; 95% CI - 1.54-5.68; P = 0.001) was more frequent in women with PCOS. CONCLUSIONS: In the studied sample, the deletion polymorphisms of the GSTT1 and GSTM1 genes isolated are not associated with PCOS, but in combination, they may be implicated in the etiology of the condition.

1 October 2020 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
SFSheila Silveira Fernandes
Sheila Silveira Fernandes
AMAlessandra Bernadete Trovó de Marqui
Alessandra Bernadete Trovó de Marqui
DTDaniela Reis Fernandes Teles
Daniela Reis Fernandes Teles
ERElisabete Aparecida Montovani Rodrigues Resende
Elisabete Aparecida Montovani Rodrigues Resende
MLMarco Fábio Prata Lima
Marco Fábio Prata Lima
MCMariângela Torreglosa Ruiz Citra
Mariângela Torreglosa Ruiz Citra
SUMMARY OBJECTIVE: The relationship between the clinicopathological and sociodemographics characteristics of acral melanomas diagnosed at BACKGROUND: This study aimed to investigate the frequency of VEGF gene insertion (I) / deletion (D) polymorphism (rs35569394) in patients with Polycystic Ovarian Syndrome (PCOS) and to compare with a control population to verify its association with the pathology. METHODS: 206 women participated in this study, 103 with PCOS (group of patients) and 103 without the disease (control group). After extraction of genomic DNA from the samples, molecular analysis was performed by Polymerase Chain Reaction (PCR) and electrophoresis in polycrylamide. Descriptive analysis, univariate analysis and logistic regression model were used. Results were presented in odds ratio (OR) and 95% confidence interval (95% CI), considering the significance of p <0.05. RESULTS: There were no statistical differences between patients and controls for allele frequencies (χ2 = 1.16, p = 0.56). The genotypic frequency distribution was in Hardy Weinberg equilibrium for the patients (χ2 = 2.42; p <0.05), but not for the control group (χ2 = 7.26; p <0.05). Regarding risk factors for the syndrome, a history of familial PCOS is more frequent among women with the syndrome. CONCLUSIONS: In the present study, there is no association between VEGF gene I / D polymorphism and PCOS.

1 July 2016 in Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo
Verified
Journal Article
Open access
BCBárbara Castro
Bárbara Castro
ERElisabete Rodrigues
Elisabete Rodrigues
ObjectivesPapillary thyroid microcarcinoma (PTMC), a tumor that measures 1cm or less, according to World Health Organization (WHO) histological classification of tumors, is the most common form of papillary thyroid carcinoma (PTC) comprising much more than half of all PTCs if one includes the so-called incidentalomas. Although PTMC has an excellent prognosis, a minority of cases were found to be clinically aggressive. We decided to perform a review of the literature on records on PTMC in attempt to find which molecular markers might be used as predictors of the clinical behavior of PTMC. This review article aims to summarize the molecular mechanisms that were associated to PTMCs described in the last 10 years, with a particular focus on the clinical importance of genetic alterations (BRAF mutation, RET/PTC rearrangement, NAD(P)H and NRH polymorphisms and TERT mutation) and anomalous expression of several molecules (P53, P27, COX-2, EGFR, ki-67, S100A4, cyclin D1, galectin-3, HMWK, CK-19, HBME-1, HGF, c-MET, membrane mucins and cell adhesion molecules).MethodsWe made a systematic search in the PubMed database using the keywords papillary thyroid microcarcinoma and reviewed all the articles published in the last 10 years, in English, addressing issues related to PTMC.ResultsUnfortunately, all genetic alterations and biomarkers reported to date have little potential per se to differentiate between indolent and aggressive PTMCs. Further studies using the aforementioned markers and, most likely, others are needed in order to try to find a combination of several markers that may be used for increasing the probability of identifying PTMC cases with more aggressive behavior, thus allowing the establishment of a more appropriately targeted treatment

26 December 2019 in Cultura de los Cuidados
Verified
Journal Article
Open access
PDF file
MSMariana Campos de Sousa
Mariana Campos de Sousa
QSQuênia Cristina Gonçalves da Silva
Quênia Cristina Gonçalves da Silva
JDJoyce Mara Gabriel Duarte
Joyce Mara Gabriel Duarte
AMAdriana Feliciana Melo
Adriana Feliciana Melo
ERElisabete Aparecida Mantovani Rodrigues de Resende
Elisabete Aparecida Mantovani Rodrigues de Resende
ÁSÁlvaro Da Silva Santos
Álvaro Da Silva Santos
Este é um estudo quantitativo, de abordagem epidemiológica, realizado com dados secundários, que objetivou avaliar as práticas de autocuidado e o grau de risco para o pé diabético em idosos com DM acompanhados em um Ambulatório de Pé Diabético de um município do interior de Minas Gerais. Utilizou-se a ficha de atendimento de idosos com DM, considerando o período de agosto de 2015 a agosto de 2016. Considerou-se 46 pessoas em atendimento no período, das quais, 54,3% eram homens; 52,2% morando com companheiro (a); com médias de: idade 68,2 anos (dp=6,3) etempo de diagnóstico de DM de 16,76 anos (dp=8,04). Em uso de biguanidas (69,6%), com doenças do aparelho circulatório (89,1%), com destaque para hipertensão arterial. A falta de exame dos pés alcançou 47,8% e dos sintomas neuropáticos os mais importantes foram: queimação, dormência e formigamento (84,6%), assim como as deformidades comuns eram: calosidades (37%), ressecamento (34,8%) e unhas grossas (32,6%). O estudo mostra a necessidade de se melhorar o monitoramento dos idosos com DM, bem como, a ampliação de ações de educação em saúde que possam ser significativas direcionadas ao melhor autocuidado dos pés, com vista a evitar complicações e manter a qualidade de vida.